Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
Crossref DOI link: https://doi.org/10.1007/s12325-016-0335-4
Published Online: 2016-05-11
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hughes, Andrew
Landers, Donal
Arkenau, Hendrik-Tobias
Shah, Saj
Stephens, Richard
Mahal, Amrik
Simmons, Matthew
Lemech, Charlotte
Royle, Jennifer
Funding for this research was provided by:
AstraZeneca